Introduction to the Olympus Scope Infection Lawsuit
- Olympus Scope Infection Lawsuit: Centers on allegations that certain reusable Olympus endoscopes and related accessories exposed patients to dangerous bacterial contamination after medical procedures.
- Eligible for an Olympus Scope Infection Lawsuit: The Law Office of Timothy L. Miles is investigating the Olympus Lawsuit Claims.
- Serious Infections: These infections can lead to hospitalization, IV antibiotic treatment, sepsis, organ failure, and death, leaving many patients with serious medical complications and lasting physical harm.
If you believe you qualify for an Olympus Scope Infection Lawsuit, contact Olympus Scope Infection Lawsuit Lawyer Timothy L. Miles today for a free case evaluation. You may be eligible for an Olympus Scope Infection Lawsuit and potentially entitled to substantial compensation in an Olympus Scope Infection Lawsuit. (855) 846–6529 or [email protected].
Serious Infection Risks Linked to Olympus Scope Procedures
- Certain reusable medical devices made by Olympus Medical Systems Corporation may have exposed patients to serious infection risks after endoscopic procedures. Several Olympus Scope Infection Lawsuits focus on Olympus duodenoscopes, which were used in ERCP procedures and later drew national scrutiny over contamination concerns.
- Lawsuits claim that some contaminated Olympus Scopes could retain biological material even after reprocessing, creating a risk that bacteria could pass from one patient to another.The danger became more serious because these devices contain intricate components and internal spaces that may remain difficult to fully disinfect under ordinary hospital conditions.
- Public reports and regulatory actions raised concerns that potentially deadly infections occur when reusable scopes are not adequately reprocessed before another procedure. Plaintiffs often argue that, even when staff followed proper cleaning protocols, the design or reprocessing demands of certain devices still left patients exposed to dangerous bacteria.
- Patients who developed severe infections, sepsis, prolonged hospitalization, or other complications after a scope procedure may have grounds to investigate a legal claim. An Olympus scope lawsuit may allow eligible patients and families to pursue compensation for medical costs, lost income, pain and suffering, and other losses tied to the infection.
Olympus Scope Lawsuit Overview: Life-Threatening Infections
- Olympus Scope Infection Lawsuits: Allege that certain reusable Olympus Medical Devices exposed patients to bacteria after endoscopic procedures.
- Claims: Involve contaminated Olympus endoscopes and related medical instruments that allegedly retained biological material in hard-to-clean areas after reprocessing.
- Federal regulators: Have acknowledged that some duodenoscope contamination risks remained even when a hospital or healthcare provider followed the manufacturer’s cleaning instructions.
- The reported injuries: Include bacterial infections caused by drug resistant organisms, including cases that led to sepsis, repeat hospitalization, and infections requiring IV antibiotics.
- Failure to File Adverse Event Reports: In 2018, Olympus pleaded guilty to federal charges for failing to report adverse events involving duodenoscope infections and paid an $85 million criminal penalty.
- Failure to Warn: Lawsuits also allege that Olympus failed to warn health officials and the public about known infection risks associated with these devices.
Recent regulatory actions add detail to those allegations:
- In January 2025, the FDA classified the MAJ-891 forceps and irrigation plug action as a Class I recall, the agency’s most serious recall category, after linking the problem to 120 injuries and one death.
- In June 2025, the FDA announced import alerts affecting certain Olympus devices manufactured in Japan.
- Trade reporting stated that the import action blocked 58 Olympus device models from future importation into the United States.
- Lawsuits cite these events as part of alleged ongoing failures in reporting, warnings, and safety controls involving reusable Olympus scope systems.
Olympus duodenoscope litigation is tied to infection transmission during procedures that patients underwent for diagnosis or treatment.
- The allegations focus on whether medical device manufacturers sold reusable scope systems that could not be reliably reprocessed under real clinical conditions.
- Those claims involve duodenoscopes, related accessories, and other Olympus products used in invasive procedures.
- Patients who developed serious infections after exposure to these devices may seek to pursue compensation for medical treatment, lost income, and other procedure-related losses.
If you believe you qualify for an Olympus Scope Infection Lawsuit, contact Olympus Scope Infection Lawsuit Lawyer Timothy L. Miles today for a free case evaluation. You may be eligible for an Olympus Scope Infection Lawsuit and potentially entitled to substantial compensation in an Olympus Scope Infection Lawsuit. (855) 846–6529 or [email protected].
What Are Olympus Scopes and How Are They Used in Medical Procedures?
Olympus Scopes: Are flexible endoscopic medical instruments developed through Olympus Endoscopy, a division of the medical device company Olympus Corporation.
Treat Internally: These devices allow physicians to view and treat internal areas of the body without open surgery by inserting a thin, camera-equipped tube through natural openings or small incisions.
Wide Range of Products: Olympus produces a wide range of scopes used across specialties, including gastrointestinal, pulmonary, urological, and surgical procedures.
ERCP Procedures: Among the most widely discussed in litigation are duodenoscopes, which are used during ERCP procedures to diagnose and treat conditions affecting the bile ducts and pancreas. These procedures often involve navigating narrow anatomical pathways, which requires devices with intricate internal components and moving parts.
Olympus Scopes: Are used in hospitals and outpatient settings as standard tools for diagnosing disease, removing blockages, taking biopsies, and guiding minimally invasive treatment.
Common procedures involving Olympus scopes include:
- Endoscopic Retrograde Cholangiopancreatography (ERCP) using duodenoscopes
- Colonoscopy and upper endoscopy procedures
- Bronchoscopy to examine the lungs and airways
- Cystoscopy and ureteroscopy for urinary tract evaluation
- Laparoscopic procedures using scope-guided surgical visualization
Olympus Scopes Linked to Infection Risk
- Olympus scopes have been repeatedly associated with infection events involving patients exposed to a contaminated device during endoscopic procedures. Internal investigations and clinical findings have identified outbreaks tied to design limitations in duodenoscopes, particularly involving antibiotic resistant infections such as carbapenem-resistant Enterobacteriaceae (CRE).
- These infections are difficult to treat and have been linked to severe complications, including sepsis and organ failure, in patients who underwent otherwise routine procedures.
- Between 2013 and 2024, contaminated Olympus duodenoscopes were connected to infections in hundreds of patients across the United States, with reports attributing at least 35 deaths to drug-resistant bacteria.
- Hospitals involved in these outbreaks faced reputational harm, regulatory scrutiny, and, in some cases, significant legal settlements tied to patient exposure.
Clinical testing has also identified positive bacterial cultures in reprocessed scopes, including findings showing contamination rates of approximately 4.1% with high-concern organisms. In response to infection concerns, Olympus issued an urgent field safety notice addressing risks associated with scope components and reprocessing limitations. Infections linked to Olympus scopes can manifest as severe symptoms, including fever, chills, and abdominal pain, often developing within days or weeks after the procedure.
Olympus Scope Lawsuit Overview: Life-Threatening Infections
- Olympus Scope Infection Lawsuits allege that certain reusable Olympus Medical Devices exposed patients to bacteria after endoscopic procedures. Claims involve contaminated Olympus endoscopes and related medical instruments that allegedly retained biological material in hard-to-clean areas after reprocessing.
- Design Defect: Federal regulators have acknowledged that some duodenoscope contamination risks remained even when a hospital or healthcare provider followed the manufacturer’s cleaning instructions. The reported injuries include bacterial infections caused by drug resistant organisms, including cases that led to sepsis, repeat hospitalization, and infections requiring IV antibiotics.
- In 2018: Olympus pleaded guilty to federal charges for failing to report adverse events involving duodenoscope infections and paid an $85 million criminal penalty. Lawsuits also allege that Olympus failed to warn health officials and the public about known infection risks associated with these devices.
Recent regulatory actions add detail to those allegations:
- In January 2025, the FDA classified the MAJ-891 forceps and irrigation plug action as a Class I recall, the agency’s most serious recall category, after linking the problem to 120 injuries and one death.
- In June 2025, the FDA announced import alerts affecting certain Olympus devices manufactured in Japan.
- Trade reporting stated that the import action blocked 58 Olympus device models from future importation into the United States.
- Lawsuits cite these events as part of alleged ongoing failures in reporting, warnings, and safety controls involving reusable Olympus scope systems.
Olympus duodenoscope litigation is tied to infection transmission during procedures that patients underwent for diagnosis or treatment.
- The allegations focus on whether medical device manufacturers sold reusable scope systems that could not be reliably reprocessed under real clinical conditions.
- Those claims involve duodenoscopes, related accessories, and other Olympus products used in invasive procedures.
- Patients who developed serious infections after exposure to these devices may seek to pursue compensation for medical treatment, lost income, and other procedure-related losses.
Common procedures involving Olympus scopes include:
- Endoscopic Retrograde Cholangiopancreatography (ERCP) using duodenoscopes
- Colonoscopy and upper endoscopy procedures
- Bronchoscopy to examine the lungs and airways
- Cystoscopy and ureteroscopy for urinary tract evaluation
- Laparoscopic procedures using scope-guided surgical visualization
Types of Bacterial Infections Linked to Contaminated Scopes
- Procedures involving Olympus scopes have been linked to several serious bacterial infections, especially when bacteria remain on a scope after reprocessing.
- FDA and CDC materials on duodenoscopes describe how complex parts can make these devices harder to fully clean, which helps explain why contamination has remained a concern even after disinfection steps.
- Olympus Scopes have been linked to infections involving CRE (carbapenem-resistant Enterobacteriaceae), a group of antibiotic-resistant bacteria that can lead to sepsis, organ failure, or other life-threatening complications.
- Reports and outbreak investigations have also identified E. coli, Klebsiella, and Pseudomonas in connection with contaminated endoscopes, and a multicenter study found high-concern organisms on 4.1% of sampled Olympus duodenoscopes after reprocessing.
- Unlike ordinary bacterial infections, these infections can become more serious more quickly and leave injured patients facing longer hospital stays, stronger antibiotics, and a more difficult recovery.
Severe Complications Following Infection
- A bacterial infection after a scope procedure can move quickly from localized illness to a medical emergency.
- Sepsis is the body’s extreme response to an infection and can rapidly lead to tissue damage, organ failure, and death without prompt treatment.
- Bloodstream infections can also spread bacteria through the body, which is one reason many patients need hospitalization, IV antibiotics, repeat testing, and close monitoring after exposure to contaminated medical devices.
- Severe infection may also trigger septic shock, a condition marked by dangerously low blood pressure and reduced blood flow to vital organs such as the kidneys, lungs, heart, and brain.
- These complications help explain why Olympus scope claims often involve long recoveries, intensive care, or death rather than a short course of treatment.
Severe complications linked to infection can include:
- Sepsis: A life-threatening reaction to infection that can cause tissue damage, organ failure, and death.
- Bloodstream infection: Bacteria enter the blood and spread through the body, increasing the risk of systemic illness and rapid decline.
- Septic shock: An advanced form of sepsis involving dangerously low blood pressure and reduced blood flow to vital organs.
- Organ failure: Severe infection can damage the kidneys, lungs, liver, heart, or brain.
- Acute respiratory distress syndrome (ARDS): A serious lung condition that reduces oxygen in the blood and can develop during severe infection or sepsis.
- Disseminated intravascular coagulation (DIC): Abnormal clotting throughout the bloodstream that can block blood flow, damage organs, and later cause severe bleeding.
- Permanent organ damage: Some patients survive sepsis but are left with lasting kidney or other organ injury.
- Death: Overwhelming infection may become fatal, especially once sepsis or septic shock develops.
Olympus Recalls and Safety Alerts
- Olympus has been the subject of multiple FDA safety actions involving endoscopes and related accessories used in invasive procedures. These actions include recalls tied to infection risk, device failure, and manufacturing issues affecting patient safety.
- Several of the affected products were used repeatedly between patients, which increased the consequences of contamination or mechanical defects. The FDA has also taken enforcement action against Olympus based on findings of violations of quality system regulations at manufacturing facilities.
- Earlier regulatory scrutiny involved devices such as the TJF Q180V duodenoscope, which was associated with infection reporting failures and reprocessing concerns. These regulatory actions required changes in how certain devices were used, cleaned, distributed, or removed from clinical settings.
Olympus recalls and safety alerts include:
- December 2024 / January 2025: The FDA posted a Class I recall for the MAJ-891 Forceps/Irrigation Plug, linked to the risk of transferring biomaterial between uses, with reports of 120 injuries and one death.
- January 2025: Olympus issued a voluntary recall for an endoscope accessory due to infection risk involving retained biological material after reprocessing.
- June 24, 2025: The FDA issued import alerts for certain Olympus devices manufactured in Japan, citing ongoing violations of quality system regulations, with reporting indicating 58 affected models.
- September 30, 2025: The FDA issued a Class I recall for certain ViziShot 2 FLEX endoscopic aspiration needles due to a design defect linked to patient injury and at least one reported death.
FDA actions required hospitals and medical professionals to stop using certain devices, follow updated instructions, or transition to alternative products.
Olympus Devices Involved in Infection Lawsuits
- Olympus infection lawsuits focus first on duodenoscopes used in ERCP procedures, because those devices were repeatedly tied to contamination concerns, FDA action, and infection-reporting failures.
- The TJF-Q180V duodenoscope appears most often in the public regulatory record, alongside older Olympus ERCP models that FDA placed under postmarket surveillance in 2015.
- Olympus safety actions also involve other reusable scope categories and accessories used in pulmonary, urological, gynecological, and surgical procedures.
- The FDA’s June 24, 2025 import-alert letter identified specific Olympus bronchoscopes, ureterorenoscopes, laparoscopes, and automated endoscope reprocessors manufactured in Japan.
- The MAJ-891 recall involved an accessory used with compatible cystoscope, ureteroscope, choledochoscope, and
Specific Olympus devices and product lines involved in infection lawsuits or related safety actions include:
- TJF-Q180V duodenoscope: the Olympus model most closely associated with the federal infection-reporting case and FDA surveillance orders.
- JF-140F duodenoscope: one of the Olympus ERCP models included in FDA’s 2015 postmarket surveillance order.
- PJF-160 duodenoscope: another Olympus ERCP model placed under FDA surveillance because infection could result in serious adverse health consequences.
- TJF-160F duodenoscope: included in the same FDA order covering Olympus ERCP scope models.
- TJF-160VF duodenoscope: also named in FDA’s 2015 postmarket surveillance order.
- MAJ-891 Forceps/Irrigation Plug: a reusable accessory attached to certain Olympus scopes, including CYF, URF, CHF, and HYF series devices.
- Certain Olympus bronchoscopes, ureterorenoscopes, laparoscopes, and automated endoscope reprocessors: device categories identified in FDA’s June 24, 2025 import-alert action.
Olympus scope litigation includes both devices used directly during procedures and accessories or reprocessing systems tied to contamination control. Duodenoscope claims remain the main body of the infection cases. Later safety actions expanded the device list beyond ERCP products alone.